2022-08-08 18:26:40 | 262
Square and Renata for Covid oral medicine production

Six other pharmaceutical companies are also waiting for the green light The Directorate General of Drug Administration (DGDA) has granted Beximco, Square, Eskayef and Renata pharmaceutical companies approval for the production and marketing of molnupiravir, the first-ever Covid-19 pill developed by US drugmaker Merck & Co Inc and Ridgeback Biotherapeutics.